scispace - formally typeset
Open AccessJournal ArticleDOI

New Mechanisms of Pulmonary Fibrosis

Robert M. Strieter, +1 more
- 01 Nov 2009 - 
- Vol. 136, Iss: 5, pp 1364-1370
TLDR
This review discusses evolving conceptual mechanisms for the pathogenesis of pulmonary fibrosis relevant to idiopathic pulmonary fibrot, including the importance of the integrity of the alveolar-capillary barrier basement membrane to conserving the architecture of the injured lung.
About
This article is published in Chest.The article was published on 2009-11-01 and is currently open access. It has received 242 citations till now. The article focuses on the topics: Pulmonary fibrosis & Idiopathic pulmonary fibrosis.

read more

Citations
More filters
Journal ArticleDOI

Evolving challenges in hepatic fibrosis

TL;DR: Both apoptosis and senescence have been recognized as orchestrated programs that eliminate fibrogenic cells during resolution of liver fibrosis and their translation into new diagnostic tools and treatments.
Journal ArticleDOI

miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis

TL;DR: A large-scale screening for miRNAs potentially involved in bleomycin-induced fibrosis found expression of miR-29 family members significantly reduced in fibrotic lungs, and gene expression profiles of human fetal lung fibroblast IMR-90 cells in which endogenous miR -29 was knocked down strongly suggest a role of mi R-29 in the pathogenesis of pulmonary fibrosis.
Journal ArticleDOI

The pathogenesis of idiopathic pulmonary fibrosis.

TL;DR: It is shown that in the presence of persisting injurious pathways, or disrupted repair pathways, activated TGF-β can lead to enhanced epithelial apoptosis and epithelial-to-mesenchymal transition (EMT) as well as fibroblast, and fibrocyte, transformation into myofibroblasts which are resistant to apoptosis.
Journal ArticleDOI

Antifibrotic activities of pirfenidone in animal models

TL;DR: The consistent antifibrotic activity of pirfenidone in a broad array of animal models provides a strong preclinical rationale for the clinical characterisation of Pirfenidones in pulmonary fibrosis and, potentially, other conditions with a significant fibrotic component.
References
More filters
Book

Inflammation: Basic principles and clinical correlates

TL;DR: This poster describes the cellular components of Inflammation, the mechanisms of response to inflammation, and the role of cytokines in the regulation of these components.
Journal ArticleDOI

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

TL;DR: The hypothesis that idiopathic pulmonary fibrosis is a fibrotic rather than an inflammatory disease is examined, and the therapeutic implications of these findings are discussed.
Journal ArticleDOI

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

TL;DR: The targeted pulmonary expression of IL-13 causes a mononuclear and eosinophilic inflammatory response, mucus cell metaplasia, airway fibrosis, eotaxin production, airways obstruction, and nonspecific AHR in transgene-positive animals.
Journal ArticleDOI

Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

TL;DR: Blood-borne fibrocytes contribute to scar formation and may play an important role both in normal wound repair and in pathological fibrotic responses.
Journal ArticleDOI

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

TL;DR: Alveolar epithelial cells are revealed as progenitors for fibroblasts in vivo and implicate the provisional extracellular matrix as a key regulator of epithelial transdifferentiation during fibrogenesis.
Related Papers (5)